Загрузка...
PRRT of neuroendocrine tumors: individualized dosimetry or fixed dose scheme?
Great efforts have been made in dosimetry for individualizing PRRT. However, many centers do not use dosimetry and its results hardly influence treatment. A reason for that is that reliable thresholds for organs-at-risk, kidneys and bone marrow, and treatment response are lacking. The nuclear medici...
Сохранить в:
| Опубликовано в: : | EJNMMI Res |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7158965/ https://ncbi.nlm.nih.gov/pubmed/32296955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-020-00623-3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|